Enterococcus: A Predictor of Ravaged Microbiota and Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation.


Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
05 2020
Historique:
received: 28 11 2019
revised: 14 01 2020
accepted: 28 01 2020
pubmed: 6 2 2020
medline: 24 6 2021
entrez: 5 2 2020
Statut: ppublish

Résumé

Intestinal flora plays an essential role in regulating immune responses. Changes in the gut flora are associated with poor prognosis after allogeneic hematopoietic stem cell transplantation (HSCT). We aimed to investigate the impact of diverse intestinal flora on survival after allogeneic HSCT. Using next-generation sequencing of the bacterial 16S ribosomal RNA (rRNA) gene, we found that the intestinal microbiota of patients undergoing allogeneic HSCT differed significantly from that of healthy controls. Furthermore, dysbiosis persisted for at least 1 year after transplantation. Interestingly, increased abundance of the genus Enterococcus detected by 16S rRNA sequencing as early as 1 month after transplantation was correlated with poor survival (overall survival at 2 years post-HSCT, 83.9% for patients with <1% relative abundance of Enterococcus and 47.6% for those with ≥1% relative abundance of Enterococcus), which was undetectable by conventional standard stool culture. These findings suggest that detection of Enterococcus by 16S rRNA analysis reflects compromised intestinal flora and may be a promising prognostic indicator.

Identifiants

pubmed: 32018061
pii: S1083-8791(20)30052-5
doi: 10.1016/j.bbmt.2020.01.019
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1028-1033

Informations de copyright

Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Auteurs

Shinsuke Kusakabe (S)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Kentaro Fukushima (K)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. Electronic address: kfukushi@bldon.med.osaka-u.ac.jp.

Takafumi Yokota (T)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Akihisa Hino (A)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Jiro Fujita (J)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Daisuke Motooka (D)

Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Shota Nakamura (S)

Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Hirohiko Shibayama (H)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Yuzuru Kanakura (Y)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH